IM4.19-20 | Febrile Syndrome Treatment Communication — Summary & Reflection

KEY TAKEAWAYS

IM-skills arc — treatment and communication for febrile syndromes:

Step 1 (indication for empiric treatment): mandatory when probability × cost-of-delay is high — severe falciparum malaria (IV artesunate immediately), bacterial meningitis (IV ceftriaxone + dexamethasone within one hour), sepsis (Hour-1 bundle), febrile neutropenia (IV antibiotics within one hour), scrub typhus eschar (doxycycline empirically). Withhold empiric therapy in FUO workup and when diagnostic confirmation is achievable without dangerous delay.

Step 2 (governing principles): cover the most dangerous first; use narrowest effective spectrum; reassess at 48–72 hours; distinguish treatable from supportive-only (no antibiotics for dengue); modify for host immune context.

Step 3 (procedure — key regimens): severe malaria = IV artesunate 2.4 mg/kg; typhoid = ceftriaxone 1–2 g/day (fluoroquinolones resistance widespread); sepsis = piperacillin-tazobactam or meropenem + vancomycin (HCAP); TB-NTEP = 2HRZE + 4HRE daily, weight-band dosed, fixed-dose combinations; HIV-NACO = TDF/3TC/DTG once daily; TB-HIV CD4 <50 = ART within 2 weeks, double dolutegravir dose with rifampicin.

Step 4 (response assessment): 48–72 hour formal review — clinical, microbiological, and radiological; scrub typhus defervesces in 24–48 hours with doxycycline; typhoid fever resolves 3–7 days with ceftriaxone; dengue platelets fall through critical phase (normal) before recovering day 6–7.

Step 5 (communication): five components — diagnosis in plain language, treatment and why, expected course, specific observable danger signs, follow-up plan with specific dates and tests. Teach-back to verify understanding. Never start steroids for FUO without excluding TB and kala-azar.

Step 6 (self-assessment): leptospirosis in flood-exposed patient = IV benzylpenicillin empirically before serology; TB contact tracing = all household members for Mantoux + CXR; rifampicin-DTG interaction = double dolutegravir dose to 50 mg twice daily.

REFLECT

Recall the opening vignette — a patient with severe falciparum malaria, and his frightened mother asking if he would survive. In the 45 minutes of this module, you have built the framework to both treat him correctly and answer her question honestly and compassionately. Think about the last febrile patient you observed in a ward: did the treating team explicitly communicate the expected fever course and specific danger signs to the patient or family? If not, what would you add to that communication? How would you explain to a patient why they must not stop TB medicines after 2 months when they feel perfectly well — in language that they will remember and act on, not medical language that they will nod at but forget?